PALISADE BIO, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Palisade Bio, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Palisade Bio, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 28.9 %, a 58.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 28.9 +10.6 +58.1% Sep 30, 2024
Q2 2024 24.7 +4.31 +21.1% Jun 30, 2024
Q1 2024 21.1 -7.46 -26.1% Mar 31, 2024
Q4 2023 17.7 -24.4 -57.9% Dec 31, 2023
Q3 2023 18.3 -37.7 -67.3% Sep 30, 2023
Q2 2023 20.4 -101 -83.2% Jun 30, 2023
Q1 2023 28.5 -657 -95.8% Mar 31, 2023
Q4 2022 42.1 +279 Dec 31, 2022
Q3 2022 56 +170 Sep 30, 2022
Q2 2022 122 +184 Jun 30, 2022
Q1 2022 685 +707 Mar 31, 2022
Q4 2021 -236 -210 -805% Dec 31, 2021
Q3 2021 -114 -103 -932% Sep 30, 2021
Q2 2021 -62.3 -38.2 -158% Jun 30, 2021
Q1 2021 -21.6 +44.3 +67.2% Mar 31, 2021
Q4 2020 -26.1 -205 -115% Dec 31, 2020
Q3 2020 -11 -50.5 -128% Sep 30, 2020
Q2 2020 -24.2 -78.6 -144% Jun 30, 2020
Q1 2020 -65.9 -116 -231% Mar 31, 2020
Q4 2019 179 +124 +224% Dec 31, 2019
Q3 2019 39.4 -25 -38.8% Sep 30, 2019
Q2 2019 54.4 -0.39 -0.71% Jun 30, 2019
Q1 2019 50.4 -9.26 -15.5% Mar 31, 2019
Q4 2018 55.2 -10.1 -15.4% Dec 31, 2018
Q3 2018 64.5 -10.9 -14.5% Sep 30, 2018
Q2 2018 54.8 -97.3 -64% Jun 30, 2018
Q1 2018 59.7 -188 -75.9% Mar 31, 2018
Q4 2017 65.3 -499 -88.4% Dec 31, 2017
Q3 2017 75.4 -2.36K -96.9% Sep 30, 2017
Q2 2017 152 -158 -50.9% Jun 30, 2017
Q1 2017 247 +90 +57.2% Mar 31, 2017
Q4 2016 564 +469 +492% Dec 31, 2016
Q3 2016 2.44K +2.36K +2995% Sep 30, 2016
Q2 2016 310 +249 +412% Jun 30, 2016
Q1 2016 157 +108 +217% Mar 31, 2016
Q4 2015 95.2 +52.5 +123% Dec 31, 2015
Q3 2015 78.7 +32.4 +70% Sep 30, 2015
Q2 2015 60.6 +2.12 +3.63% Jun 30, 2015
Q1 2015 49.6 -34.4 -41% Mar 31, 2015
Q4 2014 42.8 -110 -72.1% Dec 31, 2014
Q3 2014 46.3 -79.2 -63.1% Sep 30, 2014
Q2 2014 58.5 -29.7 -33.7% Jun 30, 2014
Q1 2014 84.1 +21.8 +35% Mar 31, 2014
Q4 2013 153 +120 +359% Dec 31, 2013
Q3 2013 126 +78.6 +167% Sep 30, 2013
Q2 2013 88.1 +23 +35.3% Jun 30, 2013
Q1 2013 62.3 +14.1 +29.3% Mar 31, 2013
Q4 2012 33.4 Dec 31, 2012
Q3 2012 47 Sep 30, 2012
Q2 2012 65.1 Jun 30, 2012
Q1 2012 48.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.